Literature DB >> 25330298

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita.

Hiroaki Iwata1, Elena Pipi1, Nicole Möckel1, Peter Sondermann2, Artem Vorobyev3, Nina van Beek1, Detlef Zillikens3, Ralf J Ludwig4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25330298     DOI： 10.1038/jid.2014.451

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  15 in total

Review 1.  Emerging treatment for epidermolysis bullosa acquisita.

Authors:  L Engineer; A R Ahmed
Journal:  J Am Acad Dermatol       Date:  2001-05       Impact factor: 11.527

Review 2.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

3.  Recombinant soluble receptors for the Fc gamma portion inhibit antibody production in vitro.

Authors:  N Varin; C Sautès; A Galinha; J Even; P M Hogarth; W H Fridman
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

Review 4.  The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies.

Authors:  Mattias Collin; Marc Ehlers
Journal:  Exp Dermatol       Date:  2013-06-28       Impact factor: 3.960

5.  The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model.

Authors:  S E McKenzie; S M Taylor; P Malladi; H Yuhan; D L Cassel; P Chien; E Schwartz; A D Schreiber; S Surrey; M P Reilly
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

Review 6.  Emerging treatments for pemphigoid diseases.

Authors:  Ralf J Ludwig; Kathrin Kalies; Jörg Köhl; Detlef Zillikens; Enno Schmidt
Journal:  Trends Mol Med       Date:  2013-07-04       Impact factor: 11.951

Review 7.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

8.  Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.

Authors:  Sofia E Magnusson; Maria Andrén; Kajsa E Nilsson; Peter Sondermann; Uwe Jacob; Sandra Kleinau
Journal:  Clin Immunol       Date:  2008-03-17       Impact factor: 3.969

9.  B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.

Authors:  Hiroaki Iwata; Katja Bieber; Benjamin Tiburzy; Navina Chrobok; Kathrin Kalies; Atsushi Shimizu; Sarah Leineweber; Akira Ishiko; Artem Vorobyev; Detlef Zillikens; Jörg Köhl; Jürgen Westermann; Karsten Seeger; Rudolf Manz; Ralf J Ludwig
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

10.  Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors.

Authors:  S Kleinau; P Martinsson; B Heyman
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307
View more
  6 in total

Review 1.  Translating Inhibitory Fc Receptor Biology into Novel Therapeutic Approaches.

Authors:  Falk Nimmerjahn
Journal:  J Clin Immunol       Date:  2016-03-08       Impact factor: 8.317

Review 2.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

3.  Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Authors:  Misa Hirose; Anika Kasprick; Foteini Beltsiou; Katharina Dieckhoff Schulze; Franziska Sophine Schulze; Unni Kjsrl Samavedam; Jennifer E Hundt; Hendri H Pas; Marcel F Jonkman; Enno Schmidt; Kathrin Kalies; Detlef Zillikens; Ralf J Ludwig; Katja Bieber
Journal:  Mol Med       Date:  2016-12-20       Impact factor: 6.354

Review 4.  The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.

Authors:  Peter Sondermann
Journal:  J Clin Immunol       Date:  2016-04-02       Impact factor: 8.317

Review 5.  Fc gamma receptors: glycobiology and therapeutic prospects.

Authors:  Jerrard M Hayes; Mark R Wormald; Pauline M Rudd; Gavin P Davey
Journal:  J Inflamm Res       Date:  2016-11-16

Review 6.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.